메뉴 건너뛰기
Clinical Nephrology
Volumn 78, Issue 3, 2012, Pages 250-250
Therapeutic resistance to ACEI and ARB combination in macroalbuminuric diabetic nephropathy
Author keywords

[No Author keywords available]
Indexed keywords

ANGIOPOIETIN 1; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; VASCULOTROPIN RECEPTOR 1;
EID: 84867672811     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107538     Document Type: Letter
Times cited : (3)
References (6)
  • 1
    • 82155173194 scopus 로고    scopus 로고
    • ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a doubleblind randomized clinical trial
    • PubMed
    • Titan SM, M Vieira J Jr, Dominguez WV, Barros RT, Zatz R. ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a doubleblind randomized clinical trial. Clin Nephrol. 2011; 76: 273-283. PubMed
    • (2011) Clin. Nephrol. , vol.76 , pp. 273-283
    • Titan, S.M.1    Vieira Jr., M.J.2    Dominguez, W.V.3    Barros, R.T.4    Zatz, R.5
  • 2
    • 33645411211 scopus 로고    scopus 로고
    • Early detection of endothelial injury and dysfunction in conjunction with correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy
    • PubMed
    • Futrakul N, Butthep P, Vongthavarawat V, Futrakul P, Sirisalipoch S, Chaivatanarat T, Suwanwalaikorn S. Early detection of endothelial injury and dysfunction in conjunction with correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy. Clin Hemorheol Microcirc. 2006; 34: 373-381. PubMed
    • (2006) Clin. Hemorheol. Microcirc. , vol.34 , pp. 373-381
    • Futrakul, N.1    Butthep, P.2    Vongthavarawat, V.3    Futrakul, P.4    Sirisalipoch, S.5    Chaivatanarat, T.6    Suwanwalaikorn, S.7
  • 3
    • 80054961684 scopus 로고    scopus 로고
    • Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes
    • doi:10.1155/2011/971524, PubMed
    • Futrakul N, Futrakul P. Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes. Int J Vasc Med. 2011; 2011: 971524. doi:10.1155/2011/971524 PubMed
    • (2011) Int. J. Vasc. Med. , vol.2011 , pp. 971524
    • Futrakul, N.1    Futrakul, P.2
  • 4
    • 79952648853 scopus 로고    scopus 로고
    • Enhanced peritubular capillary flow and renal function can be accomplished in normoalbuminuric type 2 diabetic nephropathy
    • doi:10.3109/0886022X.2011.560405, PubMed
    • Futrakul N, Kulaputana O, Futrakul P, Chavanakul A, Deekajorndech T. Enhanced peritubular capillary flow and renal function can be accomplished in normoalbuminuric type 2 diabetic nephropathy. Ren Fail. 2011; 33: 312-315. doi:10.3109/088602 2X.2011.560405 PubMed
    • (2011) Ren. Fail. , vol.33 , pp. 312-315
    • Futrakul, N.1    Kulaputana, O.2    Futrakul, P.3    Chavanakul, A.4    Deekajorndech, T.5
  • 6
    • 84871691748 scopus 로고    scopus 로고
    • Vascular repair is adequately functional in early stage of diabetic nephropathy
    • Futrakul N, Futrakul P. Vascular repair is adequately functional in early stage of diabetic nephropathy. Asian Biomed. 2010; 4: 987-990.
    • (2010) Asian Biomed. , vol.4 , pp. 987-990
    • Futrakul, N.1    Futrakul, P.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.